GLOBIPHARM
ActiveGLOBIPHARM has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91k and a net result of €16k. Equity is growing by ~51.1% per year across the filed fiscal years. Its solvency ranks better than 31% of 11165 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability90▼-10
Solvency11▲+2
Growth78=
Stability100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days only on tighter terms
Liquidity short (current ratio 0.25 against 0.3 in 2024), and 83.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
16.8%
Return on assets
3%
Age of the figures
11 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 09-04-2026, 21 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
21 d early
2024
on the day
2023
27 d early
2022
30 d early
2021
5 d early
2020
32 d early
2019
35 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€91k▲ 22.0%
2024 · €74k
2018: €-13k
2019: €1k
2020: €3k
2021: €9k
2022: €45k
2023: €55k
2024: €74k
2018 → 2025
Total assets
€541k▼ 5.5%
2024 · €572k
2018: €946k
2019: €911k
2020: €880k
2021: €718k
2022: €649k
2023: €624k
2024: €572k
2018 → 2025
Net result
€16k▼ 16.5%
2024 · €20k
2018: €16k
2019: €15k
2020: €1k
2021: €46k
2022: €36k
2023: €30k
2024: €20k
2018 → 2025
Working capital
€-62k▼ 20.3%
2024 · €-52k
2018: €27k
2019: €34k
2020: €37k
2021: €-36k
2022: €-30k
2023: €-45k
2024: €-52k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€9k-€45k▲ 400%€55k▲ 22.2%€74k▲ 35.8%€91k▲ 22.0%
Operating result€72k-€43k▼ 40.2%€48k▲ 12.4%€35k▼ 26.8%€31k▼ 13.0%
Net result€46k-€36k▼ 22.6%€30k▼ 16.5%€20k▼ 34.4%€16k▼ 16.5%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 13% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €541k
Fixed assets
€520k▼ 5.4%
Current assets
€21k▼ 8.2%
Equity and liabilities €541k
Equity
€91k▲ 22.0%
Debt
€450k▼ 9.6%
The debt ratio falls from 87.0% to 83.2%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€60k▼
2024 · €65k
Cash flow
€46k▼
2024 · €49k
Solvency
16.8%▲
2024 · 13.0%
Current ratio
0.25▼
2024 · 0.30
Quick ratio
0.25▼
2024 · 0.30
Debt / equity
4.95▼
2024 · 6.69
ROE
18.1%▼
2024 · 26.4%
ROA
3.0%▼
2024 · 3.4%
Interest coverage
7.37▼
2024 · 7.61
Debt
€450k▼
2024 · €498k
Debt ≤ 1 year
€83k▲
2024 · €74k
Debt > 1 year
€367k▼
2024 · €424k
Income taxes
€6k▼
2024 · €7k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€572k€541k▼
Fixed assets21/28€550k€520k▼
Tangible fixed assets22/27€550k€520k▼
Land and buildings22€546k€519k▼
Plant, machinery and equipment23€3k€1k▼
Current assets29/58€22k€21k▼
Amounts receivable within one year40/41€20k€17k▼
Trade receivables40€18k€14k▼
Other amounts receivable41€2k€2k=
Cash at bank and in hand54/58€2k€3k▲
Deferred charges and accrued income490/1€729€1k▲
Equity and liabilities
Total equity and liabilities10/49€572k€541k▼
Equity10/15€74k€91k▲
Contributions10/11€6k€6k=
Reserves13€68k€85k▲
Distributable reserves133€68k€85k▲
Profit (loss) carried forward14€0-
Amounts payable17/49€498k€450k▼
Amounts payable after more than one year17€424k€367k▼
Financial debts170/4€424k€367k▼
Amounts payable within one year42/48€74k€83k▲
Current portion of amounts payable after more than one year42€55k€56k▲
Trade debts44€6k€8k▲
Suppliers440/4€6k€8k▲
Taxes, remuneration and social security45€13k€11k▼
Taxes450/3€13k€11k▼
Other amounts payable47/48€0€7k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29k€29k=
Other operating charges640/8€5k€5k▲
Gross operating margin9900€70k€66k▼
Operating profit (loss)9901€35k€31k▼
Financial charges65/66B€9k€8k▼
Recurring financial charges65€9k€8k▼
Profit (loss) for the period before taxes9903€27k€23k▼
Income taxes67/77€7k€6k▼
Profit (loss) for the period9904€20k€16k▼
Profit (loss) for the period to be appropriated9905€20k€16k▼
Appropriation of the result
Profit (loss) to be appropriated9906€20k€16k▼
Profit (loss) brought forward from the previous period14P€0-
Transfer to equity691/2€20k€16k▼
To other reserves6921€20k€16k▼
Profit to be distributed694/7€0-
Directors or managers695€0-
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
03-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
25-04
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-09
Financial
Highest result since 2018net €46k ▲3900%
Operating result €72k, net result €46k, both a record.
29-03
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-09
Financial
Weakest financial yearnet €1k ▼92.1%
Net result drops to €1k, the lowest in the series; recovery starts the following year.
26-03
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
25-04
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
29-03
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
26-04
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kontich · 1 establishment unit since 2012
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Satenrozen 6A2550 KontichGround area
1.3 ha
Building footprint
2,300 m²
Volume, LiDAR
3 m³
Parcel 11024G0341/00A000, Flanders · tallest building 0.4 m. Linked by address, not a title deed.
1 establishment unit
Satenrozen 6A, 2550 Kontich
since 20122.208.430.969
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11024G0341/00A000 | Flanders | 1.3 ha | 1 · 2,300 m² | 0.4 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
A en R
BE 0566.921.646
Antwerpen · Eq €91k
SODIB
BE 0432.333.849
Sint-Pieters-Leeuw · Eq €91k
LUSOBEL
BE 0696.609.953
Elsene · Eq €91k
GLOBAL TASTE
BE 0799.870.512
Oud-Turnhout · Eq €90k
IQBAL.SATI
BE 0556.970.139
Colfontaine · Eq €90k
Of 1,631 companies in sector 46170 we hold annual accounts for 660. 464 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-01-2012
Fiscal year end30-09
Activities, NACEBEL
46170Agents in the wholesale of food, beverages and tobacco
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Data from official sources, last processed on 11-09-2026. Scores and ratios are computed by Checked and are not a credit decision.